• 沒有找到結果。

台灣Acinetobacter baumannii臨床分離菌株攜帶Metailo-B-Lactamase基因及Integrons分子 特性之探討

N/A
N/A
Protected

Academic year: 2022

Share "台灣Acinetobacter baumannii臨床分離菌株攜帶Metailo-B-Lactamase基因及Integrons分子 特性之探討"

Copied!
3
0
0

加載中.... (立即查看全文)

全文

(1)

台灣Acinetobacter baumannii臨床分離菌株攜帶Metailo-B-Lactamase基因及Integrons分子 特性之探討

林傑裕、劉淑瑛,邱政洵

E-mail: 9314525@mail.dyu.edu.tw

摘 要

Acinetobacter baumannii 為醫院中造成院內感染常見的菌 株,由於臨床上抗生素的使用頻繁,形成了多重抗藥菌株,造成 治療上的困難。根據台大醫院對此多重抗藥菌株研究的統計數據 顯示,從1998 年篩選到的0%到2000 年的6.5%,有逐年 增加的 趨勢,可見此菌株抗藥性之快速傳播及其嚴重性。故本研究的目 的,就是希望從分子學上了解此菌株是攜帶何種 抗藥基因和其散 播的主要機制。 在醫院臨床中受A. baumannii 感染後所使用之治療藥物以β- 內醯胺類之抗生素

“imipenem”為主,故本研究主要探討對於 imipenem 具抗藥性的A. baumannii。研究之菌株來源,是由嘉義 長庚醫院所 分離到188 株之A. baumannii,再以紙綻擴散感受性試 驗檢測其抗藥性,從中篩選到2 株具imipenem 抗藥性的菌株 (P-78 和P-210),再加上由林口長庚醫院所篩選到6 株imipenem 抗藥菌株 (AB-394、AB-1756、AB-1757、AB-1758、AB-1759 和 AB-1760),共8 株進行其imipenem 抗藥性比對和研究分析。並從 菌株中再挑出只對imipenem 不具抗藥性的菌株 (P-21 和P-23) 和 對所有抗生素都不具抗藥性的菌株 (P-2) 進行分析,以了解其抗 藥基因散播的情形。 為了解抗藥菌株是否存在 常見對imipenem 抗藥之metallo-β -lactamase (例如blaIMP、blaVIM 與cfiA) 的基因,因此由已知的 blaIMP、blaVIM 與cfiA 序列設計出適當引子,再以PCR 的方法確 認出其中的AB-394 和P-78 兩株菌株具有blaIMP-1 的抗藥基因。相 對地,P-210

、AB-1756、AB-1757、AB-1758、AB-1759 和AB-1760 則不具有blaIMP、blaVIM 或cfiA 其中任一種之抗藥基因。此外,為 了進一步研究抗藥基因的位置,以快速分離質體DNA (Kado and Liu) 之方法,分離出這8 株抗藥菌株之質體與染色體,並 轉漬至 尼龍膜 (nylon membrane) 上,再以blaIMP-1 序列為探針做南方雜 交法實驗。結果發現AB-394 所攜帶的抗藥基因位 於大質體 (>100 kb) 上,P-78 所攜帶的抗藥基因則位於約95-kb 的質體上。而 P-210、AB-1756、AB-1757、AB-1758

、AB-1759 和AB-1760 則 不帶有質體,因此若攜帶抗藥基因則很可能位於染色體中。同時 進一步分析菌株中是否帶有散播 抗藥基因之“integon”結構,根據 臨床中最常被發現之integon I 序列設計引子,再以PCR 的方法確 認出P-21、P-23、P-78

、P-210、AB-394、AB-1756、AB-1757、 AB-1758、AB-1759 和AB-1760,共10 株菌株具有散播抗藥基因 之integron I 之結 構。將PCR 產物經純化解序比對後發現,AB-394 與P-78 具有相同之integron I 之結構及序列,並且攜帶有imipenem 抗藥 之blaIMP-1 基因。但在抗藥菌株P-210、AB-1756、AB-1757、 AB-1758、AB-1759 和AB-1760 之integron I 結構中未發現對 imipenem 抗藥之基因。至於這些菌株攜帶何種抗藥基因,或是其 它的抗藥機制,則需進一步研究。同時也藉由脈衝式膠 體電泳 (pulsed-field gel electrophoresis, PFGE) 之分子分型方法,分析其 抗藥菌株與非抗藥菌株之間的遺傳差異與親源性。

結果顯示多重 抗藥菌株AB-1758、AB-1759、AB-1760 和P-23 可能來自同一親 源,而P-21 和P-210 顯然具相同的親源,此 結果也顯示近期從林 口長庚醫院所篩選到的臨床多重抗藥菌株,很可能源自同一親源 (same clone)。 目前對於台灣臨床菌 株A. baumannii 之抗藥基因及integron 的探討才剛起步,本研究之結果將有助於台灣臨床A. baumannii 感染之控制及流行病 學之了解。

關鍵詞 : Acinetobacter baumannii,抗藥基因,integron,PFGE 目錄

封面內頁 簽名頁 授權書---iii 中文摘要---v 英文摘要---viii 誌 謝---xi 目錄---xii 圖目錄---xvi 表目

錄---xviii 第一章 前言---1 1.1Acinetobacter baumannii簡介---1 1.2抗生素之簡介 ---2 1.3細菌對抗抗生素之策略---3 1.4β-內醯胺?---4 1.5Metallo-

β-lactamse---6 1.6抗藥基因之傳播---7 1.7integron介紹 ---8 1.7.1 integron之構

造---9 1.7.2 integron之種類---9 1.7.3 基因片匣的構造---11 1.7.4 integron與基因片匣之表現----11 1.7.5 integron與基因片匣在抗藥性基因散佈之角色----12 1.8 脈衝式膠體電泳(Pulsed-field gel electrophoresis,PFGE)---13 1.9 研究動 機及目的---14 第二章 材料與方法---16 2.1 菌株來源---16 2.2 E-test最低抑 菌抗生素濃度---16 2.3 偵測imipenem抗藥基因及integron之步驟----17 2.3.1 引子(primer)設計---17 2.3.2

Polymerase chain reaction;PCR---18 2.3.3 電泳分析及PCR產物分子量計算---20 2.3.4 blaimp及integron在菌體位置之 分析---20 2.3.5 PCR產物之純化---21 2.3.6 序列資料分析---22 2.4 快速抽取質體DNA(Kado and Liu)---22 2.5 南方雜交法(Southern hybridization)---23 2.5.1 薄膜轉漬(Membrane transfer)---23 2.5.2 製作探針---24 2.5.3 雜交(Hybridization)與顯影---25 2.6 脈衝式膠體電泳(PFGE)---27 第三章 實驗結果---29 3.1 E-test最低抑菌抗

(2)

生素濃度之結果分析---29 3.2 Imipenem抗藥基因之PCR結果分析---29 3.2.1 blaimp之imipenem抗藥基因---29 3.2.2 blavim之imipenem抗藥基因---30 3.2.3 cfiA之imipenem抗藥基因----31 3.3 Integron之PCR結果分析---31 3.3.1 Integron之PCR 結果---31 3.3.2 Integron PCR產物定序分析比對---34 3.4 Kado and Liu之方法分離質體---33 3.5 抗藥基因位置之分析 結果---34 3.6 脈衝式膠體電泳(PFGE)之分子分型---34 第四章 討論---36 4.1 E-test 最低抑菌抗生素濃度---36 4.2

Imipenem抗藥基因之PCR 結果討論----36 4.3 抗藥基因位置分析---38 4.4 Integron之PCR結果討論---39 4.5 脈衝式膠體 電泳(PFGE)之分子分型----41 第五章 結論---43 參考資料---77 附錄---86 附錄一 菌株感受性試 驗---86 a、紙錠擴散感受性試驗---87 b、微量稀釋感受性試驗---88 附錄二 Metallo-β-lactamase之各blaIMP 比較表---89 附錄三 Metallo-β-lactamase之各blaVIM比較表---90 附錄四 AB-394、p-78與P-210之菌株integron之比 較---91

參考文獻

1. 王景平等編譯。1991。抗微生物化學療法。醫用微生物學, p189-243,藝軒出版社。 2. 陳岳源主編。1986。抗生素。藥物化學精要, p 144-203,供學出版社。 3. 陳豪勇等編譯。2001。Pseudomonas and Related Organisms,最新 醫用微生物學(第三版), p 309-317, 藝軒出版社。

4. 陳錚誼。2001。Molecular Epidemiology and Drug Resistance -Mechanisms of Multidrug-Resistant Acinetobacter baumannii. 國 立臺灣大學 醫事技術學研究所碩士論文,台北. 5. 郭佑.。2002。微生物膜感染與抗生素抗藥性。台灣醫界. 45:15-16 6. 張仲羽。2000。Analysis of class 1 and class 2 integrons and -antibiotic-resistant gene cassettes in clinical isolates of -Escherichia coli. 高雄醫學大學醫學研究所博士論文,高雄. 7.

游璿樺。2003。淺談脈衝式電泳。PANTECH. 27:15-22 8. 蔡文城編著。1993。實用臨床微生物診斷學(第七版), p1023-1110,九洲出版社。

9. Appleman, M. D., H. Belzberg, D. M. Citron, P. N. Heseltine, A. -E. Yellin, J. Murray, and T. V. Berne. 2000. In vitro activities of -nontraditional antimicrobials against multiresistant Acinetobacter -baumannii strains isolated in an intensive care unit outbreak. -Antimicrob.

Agents Chemother. 44: 1035-1040. 10. Arakawa, Y., M. Murakami, K. Suzuki, H. Ito, S. Ohsuka, N. -Kato, R. Wacharotayankun, and M. Ohta.

1995. A novel -integron-like element carrying the metallo -β- lactamase gene -blaIMP. Antimicrob. Agents Chemother. 39: 1612-1615. 11. Bellais, S., O. Mimoz, S. Leotard, A. Jacolot, O. Petitjean and -P. Nordmann. 2002. Efficacy of β-lactams for treating -experimentally induced

pneumonia due to a carbapenemhydrolyzing -metallo-β-lactamase-producing strain of -Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:2032-2034. 12. Bush, K., G. A. Jacoby , and A. A. Medeiros.1995. A functional -classification scheme for β-lactamases and its correlation with -molecular structure. Antimicrob. Agents Chemother. 39:1211–1233 13. Chu, Y. W., M. Afzal-Shah, E. T. Houang, M. I.

Palepou, D. J. -Lyon, N. Woodford, and D.M. Livermore. 2000. IMP-4, a -novel metallo-β-lactamase from nosocomial Acinetobacter spp.

-collected in Hong Kong between 1994 and 1998. Antimicrob. -Agents Chemother. 45:710-714. 14. Chang C-Y., L- Chang, Y-H Chang, T-M Lee, and S-F Chang. -2000. Characterisation of drug resistance gene cassettes -associated with class 1 integrons in clinical isolates of -Escherichia coli from Taiwan, ROC. J. Med. Microbiol. 49: 1097- 1102 15. Daiyasu, H., K. Osaka, Y. Ishino and H. Toh. 2001. Expansion -of the zinc metallo-hydrolase family of the β-lactamase fold. -FEBS Lett. 503:1-6 16. Da Silva, G. J., M. Correia, C. Vital, G. Ribeiro, J. C. Sousa, R. -Leitao, L. Peixe, and A. Duarte.2002. Molecular -characterization of blaIMP-5, a new integron-borne metallo-β- -lactamase gene from an Acinetobacter baumannii nosocomial -isolate in Portugal. FEMS Microbiol. Lett. 24:33-39 17. Docquier, J.-D., M. L. Riccio , C. Mugnaioli, F. Luzzaro, A.

-Endimiani, A. Toniolo, G. Amicosante, and G. M. Rossolini. -2003 . IMP-12, a new plasmid-encoded metallo-β-lactamase from -a Pseudomonas putida clinical isolate. Antimicrob. Agents -Chemother. 47:1522- 1528 18. Fernandez-Cuenca, F., L. Martinez-Martinez, M. C. Conejo, -J. A.

Ayala, E. J. Perea, and A. Pascual. 2003. Relationship -between β-lactamase production, outer membrane protein and -penicillin-binding protein profiles on the activity of carbapenems -against clinical isolates of Acinetobacter baumannii. J. -Antimicrob. Chemother. 51: 565-574 19. Fluit, A.

C. and F. J. Schmitz. 1999. Class 1 integrons, gene -cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. -Infect. Dis. 18: 761-770. 20.

Galleni, M., J. Lamotte-Brasseur, G. M. Rossolini, J. Spencer, -O. Dideberg, and J. M. Frere. 2001. Standard numbering -scheme for class B β-lactamases. Antimicrob. Agents Chemother.45:660-663. 21. Giacometti, A., O. Cirioni, M. S. Del Prete, F. Barchiesi, A. -Mataloni Paggi, E.

Petrelli, and G. Scalise. 2000. Comparative -activities of polycationic peptides and clinically used -antimicrobial agents against multidrug-resistant nosocomial -isolates of Acinetobacter baumannii. J. Antimicrob. Chemother.46: 807-810 22. Gombac, F., M. L. Riccio, G. M. Rossolini, C.

Lagatolla, E. -Tonin, C. Monti-Bragadin, A. Laveni and L. Dolzani. 2002. -Molecular characterization of integrons in epidemiologically -unrelated clinical isolates of Acinetobacter baumannii from -Italian hospitals reveals a limited diversity of gene cassette arrays. -Antimicrob. Agents

Chemother. 46:3665-8. 23. Hsueh, P-R, L-J Teng, C-Y Chen, W-H Chen, C-J Yu, S-W Ho, -and K-T Luh .2002. Pandrug-resistant Acinetobacter baumannii -causing nosocomial infections in a University hospital, Taiwan. -Emerg. Infect. Dis. 8: 827-832 24. Iyobe, S., H. Kusadokoro, J. Ozaki, N. Matsumura, S. Minami, -S. Haruta, T. Sawai, and K O'Hara. 2000. Amino acid -substitutions in a variant of IMP-1 metallo-β-lactamase.

-Antimicrob. Agents Chemother. 44:2023-2027 25. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection -and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373 26. Kato N, K. Yamazoe, C. G. Han and E. Ohtsubo . 2003. New -insertion sequence elements in the upstream region of cfiA in -imipenem-resistant Bacteroides fragilis strains. Antimicrob. -Agents Chemother. 47:979-985. 27. Koeleman, J. G. M., J.

Stoof, D. J. Biesmans, P. H. M. -Savelkoul, and C. M. J. E. Vandenbroucke-Grauls. 1998. -Comparison of amplified ribosomal DNA restriction analysis, -random amplified polymorphic DNA analysis, and amplified -fragment length polymorphism fingerprinting for identification of -Acinetobacter genomic species and typing of Acinetobacter -baumannii. J. Clin. Microbiol. 36: 2522-2529. 28. Koeleman, J. G., J. Stoof, C. M.

(3)

Vandenbroucke-Grauls, M. -W. Van Der Bijl, and P. H Savelkoul. 2001 . Identification of -epidemic strains of Acinetobacter baumannii by integrase gene -PCR. J. Clin. Microbiol. 39: 8-13. 29. Kuo L-C, L-J Teng, C-J Yu, S-W Ho, and P-R Hsueh. 2004. -Dissemination of a clone of unusual phenotype of pandrugresistant -Acinetobacter baumannii at a University hospital in -Taiwan. J. Clin. Microbiol. 42: 1759-1763. 30. Lee, K., J. B. Lim, J. H. Yum, D. Yong, Y. Chong, J. M. Kim, -and D. M. Livermore. 2002. blaVIM-2 cassette-containing novel -integrons in metallo- β-lactamase-producing Pseudomonas -aeruginosa and Pseudomonas putida isolates disseminated in a -Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058. 31. Limansky A. S., M. A. Mussi and A. M. Viale. 2002 . Loss of a -29-kilodalton outer membrane protein in Acinetobacter -baumannii is associated with imipenem resistance. J. Clin. -Microbiol. 40:4776-4778. 32. Livermore, D. M. 1997. Acquired carbapenemases. J. Antimicrob. -Chemother. 39:673–676 33. Livermore, D. M. 1998. β-Lactamase-mediated resistance and -opportunities for its control. J. Antimicrob. Chemother. 41: 25–41 34. Oh, E. J., S. Lee, Y. J. Park, J. J. Park, K. Park, S. I. Kim, M. -W. Kang and B. K. Kim.

2003. Prevalence of metallo-β- -lactamase among Pseudomonas aeruginosa and Acinetobacter -baumannii in a Korean University hospital and comparison of -screening methods for detecting metallo-β-lactamase. J. -Microbiol. Methods. 54:411-418. 35. Page, M. I. 2002. Understanding metallo-β-lactamases. ASM News. 68:217-221 36. Pallecchi L, M. L. Riccio, J. D. Docquier, R. Fontana and G. M. -Rossolini 2001. Molecular heterogeneity of blaVIM-2- containing -integrons from Pseudomonas aeruginosa plasmids encoding the -VIM-2 metallo-β-lactamase. FEMS Microbiol. Lett. 20; 145-50. 37. Paul-Soto, R., R. Bauer, J.-M. Frere, M. Galleni, W. -Meyer-Klaucke, H. Nolting, G. M. Rossolini, D. Seny, M.

-Hernandez-Valladares, M. Zeppezauer and H.-W. Adolph . -1999 . Mono- and binuclear Zn2+-β-lactamase . J Biol. Chem.274: 13242-13249 38. Ploy, M. C., D. Francois, C. Patrice, and L. Thierry. 2000. -Molecular characterization of integrons in Acinetobacter -baumannii: description of a hybrid class 2 integron. Antimicrob. -Agents Chemother. 44: 2684-2688 39. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. -Cavallo and P. Nordmann . 2000. Characterization of VIM-2, a -carbapenem-hydrolyzing metallo-β-lactamase and its plasmidand -integron-borne gene from a Pseudomonas aeruginosa clinical -isolate in France. Antimicrob. Agents Chemother. 44, 891–897. 40. Riccio, M. L., N. Franceschini, Boschi, L. Caravelli, G. -Cornaglia, R. Fontana, G. Amicosante, and G. M. Rossolini. -2000. Characterization of the metallo-β-lactamase determinant of -Acinetobacter baumannii AC-54/97 reveals the existence of -blaIMP allelic variants carried by gene cassettes of different

-phylogeny. Antimicrob. Agents Chemother. 44:1229-1235. 41. Sambrook, J., E. F. Fritsch and T. Maniats. 2000. Molecular -cloning:A laboratory manual, 3rd ed. Cold Spring Harbor, NY: -Cold Spring Harbor Laboratory. 42. Seifert, H. and P. Gerner-Smidt . 1995. Comparison of

-ribotyping and pulsed-field gel electrophoresis for molecular -typing of Acinetobacter isolates. J. Clin. Microbiol. 33:1402-1407. 43. Senda, K., Y.

Arakawa, S. Ichiyama, K. Nakashima, H. Ito, S. -Ohsuka, K. Shimokata, N. Kato and M. Ohta .1996. PCR -detection of metallo-β-lactamase gene (blaIMP) in Gram- negative -rods resistant to broad-spectrumβ-lactams. Antimicrob. Agents -Chemother. 34: 2909–2913. 44. Tenover, F.

C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. -E. Murray, D. H. Persing, and B. Swaminathan. 1995. -Interpreting chromosomal DNA restriction patterns produced by -pulsed-field gel electrophoresis: criteria for bacterial strain typing. -J. Clin. Microbiol. 33:2233-2239 45. Toney, J.

H., G. G. Hammond, P. M. Fitzgerald, N. Sharma, J. -M. Balkovec, G. P. Rouen, S. H. Olson, M. L. Hammond, M. L. -Greenlee, and Y. D. Gao.

2001. Succinic acids as potent -inhibitors of plasmid-borne IMP-1 metallo-β-lactamase. J. Biol. -Chem. 24:31913-31918. 46. Urban, C., S.

Segal-Maurer and J. J. Rahal. 2003. -Considerations in control and treatment of nosocomial infections -due to multidrug-resistant Acinetobacter baumannii. Clin. Infect -Dis. 15:1268-1274. 47. Walsh, C..2000. Molecular mechanisms that confer antibacterial -drug resistance. Nature . 406, 775 – 781 48. Wang J-T, L. C. McDonald, S-C Chang, and M. Ho. 2002. -Community-acquired Acinetobacter baumannii bacteremia in -adult patients in Taiwan. J. Clin. Microbiol. 40: 1526-1529. 49. Yan J. J., P. R. Hsueh, W. C. Ko, K. T. Luh, S. H. Tsai, H. M. -Wu and J. J. Wu. 2001.

Metallo-β-lactamases in clinical -Pseudomonas isolates in Taiwan and identification of VIM-3, a -novel variant of the VIM-2 enzyme. Antimicrob.

Agents -Chemother. 45:2224-2228. 50. Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini and -Y. Chong. 2002 . Imipenem- EDTA disk method for -differentiation of metallo-β-lactamase-producing clinical isolates -of Pseudomonas spp. and Acinetobacter spp. J. Clin.

Microbiol.40:3798- 3801 51. Yum, J. H., K. Yi, H. Lee, D. Yong, K. Lee, J. Kim, G. M. -Rossolini, and Y. Chong. 2002. Molecular

characterization of -metallo-β-lactamase-producing Acinetobacter baumannii and -Acinetobacter genomospecies 3 from Korea: identification of two -new integrons carrying the blaVIM-2 gene cassettes. J. Antimicrob. -Chemother. 49:837-840.

參考文獻

相關文件

‐ Radiolucency extending from the distal aspect of the root of the lower right 2 nd premolar to the mesial aspect of the unerupted lower right 3 rd molar, with expansion of

The growth in the number of vanco- mycin-induced thrombocytopenia cases presently seen may be associated with the increased use of the drug, especially in multiresistant patients

In conclusion, data from the present study demonstrat- ed that signs of carotid calcifications in panoramic radio- graphs are associated with future events of stroke and/or

Results We identified 19 new cases of oral syphilis (17 males, one female, and one case unknown sex) and described the clinical and histopathological features of this re-emerging

Milk and cream, in powder, granule or other solid form, of a fat content, by weight, exceeding 1.5%, not containing added sugar or other sweetening matter.

一、對抗生素Meropenem Trihydrate 具抗藥性(R 菌)和不具抗藥性(S 菌)的 Acinetobacter baumannii 菌在蛋白質電泳實驗中,比較蛋白質表現的差異。(文中所用代號: 「R

6 《中論·觀因緣品》,《佛藏要籍選刊》第 9 冊,上海古籍出版社 1994 年版,第 1

The first row shows the eyespot with white inner ring, black middle ring, and yellow outer ring in Bicyclus anynana.. The second row provides the eyespot with black inner ring